Investing.com - Editas Medicine reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Editas Medicine announced earnings per share of $-0.81 on revenue of $42.00K. Analysts polled by Investing.com anticipated EPS of $-0.85 on revenue of $4.73M.
Editas Medicine shares are down 25.34% from the beginning of the year and are trading at $11.50 , down-from-52-week-high.
Editas Medicine follows other major Healthcare sector earnings this month
Editas Medicine's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar